Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Texas Instruments Incorporated (TXN)’s Fourth Quarter and Year-End 2014 Earnings Call Transcript

Page 1 of 15

Below is transcript of the Texas Instruments Incorporated (NASDAQ:TXN)’s Fourth Quarter and Year-End 2014 Earnings Call, held on Monday, January 26, 2015, at 5:30 pm EST.  Kingdom Ridge Capital, Wallace R. Weitz & Co. and Marque Millennium Capital was among Texas Instruments Incorporated (NASDAQ:TXNshareholders at the end of the third quarter.


Texas Instruments Incorporated (NASDAQ:TXN)


Texas Instruments Incorporated (NASDAQ:TXNdesigns and makes semiconductors that the Company sells to electronics designers and manufacturers all over the world. The Company has four segments: Analog, Embedded Processing, Wireless and Other. The Company’s products, more than 100,000 orderable parts, are integrated circuits that are used to accomplish many different things, such as converting and amplifying signals, interfacing with other devices, managing and distributing power, processing data, canceling noise and improving signal resolution.


Company Representatives:

Dave Pahl – VP, Head of Investor Relations, Texas Instruments, Inc.
Kevin March – SVP & Chief Financial Officer, Texas Instruments, Inc.



Chris Danely – Citigroup
Ambrish Srivastava – BMO Capital Markets
John Pitzer – Credit Suisse
Harlan Sur – JPMorgan
Stacy Rasgon – Bernstein
Vivek Arya – Bank of America Merrill Lynch
Jim Covello – Goldman Sachs
Joe Moore – Morgan Stanley
Craig Ellis – B. Riley
Mark Lipacis – Jefferies
Timothy Arcuri – Cowen and Company
Doug Freedman – RBC Capital Markets.



Good day and welcome to the Texas Instrument Fourth Quarter 2014 and 2014 Year-End earnings conference call. At this time, I would like to turn the conference to Dave Pahl, please go ahead sir.


Dave Pahl, VP, Head of Investor Relations

Thank you and good afternoon and thank you for joining our fourth quarter and year-end 2014 earnings conference call. As usual Kevin March, TI’s Chief Financial Officer is with me today. For any of you who missed the release you can find it and relevant non-GAAP reconciliations on our web at This call is being broadcast live over the web and can be accessed through TI’s website. A replay will be available through the web.

This call will include forward-looking statements that involve risks and uncertainties that could cause TI’s results to differ materially from management’s current expectations. We encourage you to review the safe harbor statement contained in the earnings released published today as well as TI’s most recent SEC filings for a more complete description.

Before I review the quarter, let me provide some information that is important to your calendar. We plan to hold a call on February 4th at 10 o’clock AM Central Time to update our capital management strategy. Similar to what we have done for the last two years on this topic, Kevin March will provide insight into our strategy and also answer some of the most frequently asked questions.

Turning to our earnings update, the fourth quarter marked another quarter of strong progress. Our core businesses of analog and embedded processing grew again with combined revenue of 13% from a year ago. Revenue of $3.27 billion came in at the middle of the expected range that we communicated to you in October. Earnings per share was $0.76 and included a $0.05 benefit for the reinstatement of the federal research tax credit and a $0.02 benefit from gains on sale of assets. Without these two items, our earnings would have been in the middle of our expected range.

Page 1 of 15

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!